New medicine assessment change backed

The NHS should work more closely with manufacturers on assessing the benefits of new medicines rather than simply blocking access, the drug industry believes.

New drugs: UK use is low
New drugs: UK use is low

Dr Richard Barker, director general of the Association of the British Pharmaceutical Industry, said restricting access to drugs led to patients missing out on the best care available.

This means patients cannot be included in many trials and creates a spiral in which care in the UK falls behind that in other countries, he said.

Dr Barker said NICE should recognise that when a drug is launched there may be limited data as to its effectiveness and value to the NHS in practice.

Rather than blocking access, the NHS should be allowed to use the drug and studies undertaken of how patients are benefitting, he said.

The NHS could then, he argued, become a 'living laboratory for healthcare innovation'.

Dr John Jeans, chief operating officer of the Medical Research Council, said the NHS should look at whether it could cut costs simply by checking whether drugs are benefitting particular patients or not.

The health White Paper aims to reform the way that drug companies are paid for NHS medicines.

It hopes a value-based pricing system will improve NHS access to effective drugs and innovative treatment.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

UK COVID-19 vaccination programme tracker

UK COVID-19 vaccination programme tracker

GPs across the UK are playing a leading role in the largest-ever NHS vaccination...

CVT risk from COVID-19 infection 'significantly higher' than from vaccines, study suggests

CVT risk from COVID-19 infection 'significantly higher' than from vaccines, study suggests

The risk of cerebral venous thrombosis (CVT) following COVID-19 infection is eight...

‘Warm and kind’ retired Derbyshire GP dies from COVID-19

‘Warm and kind’ retired Derbyshire GP dies from COVID-19

Retired Derbyshire GP Dr Om Prakash Chawla, who was known for his warmth and kindness,...

GPs can learn from pandemic to strengthen relationship with patients, says RCGP chair

GPs can learn from pandemic to strengthen relationship with patients, says RCGP chair

General practice can build on changes to care during the COVID-19 pandemic to strengthen...

Surrey GP practice targeted by aggressive anti-vaccination poster

Surrey GP practice targeted by aggressive anti-vaccination poster

Staff at a GP surgery in Surrey have been left completely demoralised after they...

JCVI issues final guidance on phase 2 of COVID-19 vaccination programme

JCVI issues final guidance on phase 2 of COVID-19 vaccination programme

The JCVI has confirmed the next phase of the COVID-19 vaccination programme will...